The global in-vitro toxicology testing market is expected to reach USD 44.7 billion by 2022 growing at an estimated CAGR of 10.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected rise in demand can be ascribed to novel and promising technologies in analytical laboratories.
Advancement in bioinformatics based research for development of efficient software algorithms in order to carry out efficient stimulation of in-silico animal models in determination of toxicological response is expected to influence sector growth through to 2022.
Furthermore, rapid up gradation of databases that serve information for toxicity profiling and lethal dose determination of different compounds is anticipated to create significant potential for growth in this market during the forecast period.
Rise in government imposed restrictions and guidelines on usage of animals for pre-clinical research and toxicology testing is also attributive towards estimated progress in this industry.
Additionally, increasing R&D in biotechnology sector for enhancement in cell based assays and cell culture techniques, is anticipated to impart significant growth potential in this sector.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market
Further key findings from the study suggest:
·
Pharmaceutical and cosmetic industry together
accounted for almost 65% of total revenue generated in this sector for 2014.
This large share can be attributed to rapid novel product launches for
treatment of different diseased conditions wherein toxicological testing is the
pre-requisite step.
·
Cell culture technology contributed for over 42%
of the revenue generated in the industry with respect to technology owing to
critical role of cell culture in biotechnological development and cell based
analysis
·
Omics technology is anticipated to register
lucrative growth thereby driving demand due to advancement in sequencing methods
and availability of different platforms depending on source and target
sequence.
·
As a fundamental process in biopharmaceutical or
pharmaceutical product development toxicological testing finds application in
determination of systemic, dermal, & ocular toxicity as well as endocrine
disruption
·
Amongst the above enlisted applications, dermal
toxicity is expected to witness significant progress with a CAGR of
approximately 13% due to comparatively higher incidence of side effects
associated with skin after administration of several compounds.
·
North America accounted for the largest share of
over 45% in revenue in 2014 owing to presence of significant number of sector
players that are implementing advanced in-vitro technology.
Furthermore, presence of stringent regulations pertaining to animal usage in
toxicity analysis attributive towards high demand of in-vitro tests in
this region.
·
Asia Pacific is expected to witness lucrative
CAGR of over 11% from 2015 to 2022 due to rapid improvement in health care
infrastructure in developing economies of this region which in turn contributes
to regional progress in industry.
·
Key participants of in-vitro toxicology testing
industry are Quest Diagnostics, Covance, Cyprotex, Alere, Inc, Charles River
Laboratories, GE Healthcare, Thermo Fisher Scientific, Eurofins Scientific,
Inc., Agilent Technologies, Catalent Pharma Solutions, Sigma Aldrich, and
Bio-Rad.
·
These participants are involved in
collaborations with bioinformatics research firms in order to develop novel in-silico
algorithms for computational estimation of toxicity of pharmaceutical and
chemical products.
·
Moreover, these market entities are also
focusing on entering untapped regions in order to maintain their share in
market revenue.
Browse All Reports of
this category @ http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented in-vitro toxicology testing market on the basis of end use, technology, method, application, and region:
Global In-vitro Toxicology Testing Outlook, by End-use (Revenue, USD Million, 2012 – 2022)
·
Pharmaceutical industry
·
Cosmetics & household products
·
Diagnostics
·
Chemical industry
·
Food industry
Global In-vitro Toxicology Testing
Technology Outlook (Revenue, USD Million, 2012 – 2022)
·
Cell culture technology
·
High throughput technology
·
Molecular imaging
·
OMICS technology
Global In-vitro Toxicology Testing
Outlook, by Application (Revenue, USD Million, 2012 – 2022)
·
Systemic Toxicology
·
Dermal Toxicity
·
Endocrine Disruption
·
Occular toxicity
Global In-vitro Toxicology Testing
Outlook, by Method (Revenue, USD Million, 2012 – 2022)
·
Cellular Assay
·
Biochemical Assay
·
In-Silico
·
Ex-vivo
In-vitro Toxicology Testing Regional Outlook (Market
Revenue in USD Million, 2012 - 2022 )
·
North America
·
Europe
·
Asia Pacific
·
RoW
No comments:
Post a Comment